WHO ICTRP trial
The value of exosome miR29 for biomarker of primary Sjogren's syndrome with…
ChiCTR2000035194 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000035194 |
|---|---|
| Public title | The value of exosome miR29 for biomarker of primary Sjogren's syndrome with interstitial lung disease |
| Scientific title | The value of exosome miR29 for biomarker of primary Sjogren's syndrome with interstitial lung disease |
| Primary sponsor | Tongji Hosipital, Tongji University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | Sjogren's syndrome; Interstitial lung disease |
| Interventions | Gold Standard:According to the clinical manifestations, chest imaging (cell-like change, ground glass change, solid shadow, mesh shadow), lung ventilation and diffusion function (FVC, DLCO), pathological biopsy and the elimination of ILD… |
| Registration date | Aug 2, 2020 |
| Target size | Target condition:60;Difficult condition:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: